Mark Johnson, MRCP MBBCh BSc1
(1) Department of Long-Term Unscheduled Care, Harrogate and District Foundation Trust, Lancaster Park Road, Harrogate, Yorkshire, UK
Download article PDF – POCUS Journal 2024; 9(1):36-40.
DOI: https://doi.org/10.24908/pocus.v9i1.16660
Supplementary Material: Video S1; Video S2; Video S3; Video S4
Abstract
In acute care environments, accurately assessing complications of intracranial pathology can be challenging. Ocular complications in acute intracranial disease are not consistently evaluated despite their high morbidity. We report on a case of monocular diplopia in a 63-year-old man with subacute traumatic brain injury with localized subarachnoid hemorrhage. Ocular point of care ultrasound (POCUS) identified features of vitreous hemorrhage in one globe, leading to a diagnosis of Terson syndrome and a timely referral to ophthalmology. This finding was made on the medical floor days after the initial presentation during rehabilitation when ophthalmoscopy was not possible, and vitreous hemorrhage had not been identified on presentation. Terson syndrome is a seldom discussed but important complication of intracranial hemorrhage generally associated with poor patient outcomes. Ocular POCUS can provide a useful alternative in assessing ocular complications of acute intracranial disease on the medical floor, particularly when the practicalities of performing ophthalmoscopy are challenged.
Introduction
Managing intracranial pathology and its associated complications is a common challenge for acute care providers. Intracranial pathology can present with a myriad of signs and symptoms which may be challenging to elicit through examination alone [1]. As well, many of these complications gain increasing morbidity and mortality in our ageing population [1]. Regardless of traumatic or non-traumatic mechanisms, ocular manifestations of intracranial pathology can range from clinically apparent to subtle, with most presentations having potentially sight-threatening outcomes [2]. As a result, ophthalmoscopy is often advised to complete the evaluation of a patient with suspected intracranial pathology. Such patients can be difficult to interview or examine for visual disturbance – particularly in cases of altered mental status commonly associated with intracranial pathology – complicating accurate clinical evaluation.
It can be challenging to assess the visual system in acute care settings. The challenges include a need to monitor pupillary responses in acute intracranial injury precluding mydriasis, the inability to darken specific environments, and reduced access to ophthalmoscopy equipment in certain locations, such as resuscitation areas [3]. As a result of these factors, 59% of ocular assessments in the Emergency Department are deemed inadequate [4]. These factors have led to a compounding cycle of increasing reliance on specialist assessment, reduced non-specialist competence, and reduced engagement in medical education [5].
In an era of point of care ultrasound (POCUS) expansion, increasing access to linear sonographic devices and decline of non-specialist ophthalmology, it is worth recalling the benefits of ocular POCUS. Here we demonstrate a case where ocular POCUS identified ocular complications of traumatic intracranial pathology, specifically traumatic cerebral contusion with localised subarachnoid hemorrhage. This complication had not been identified during the patient’s initial assessment despite thorough review from numerous clinicians. The diagnosis of this complication in the care of acute intracranial pathology patients can reduce morbidity through expediting access to specialist care to preserve sight as well as provide useful prognostic information at the bedside.
Case Report
A 63-year-old man presented to the Emergency Department suffering with irretractable nausea and vomiting with concomitant severe headache following a fall at home three days prior. The fall occurred from a standing height and was associated with minor abrasions to the forehead. The patient’s family highlighted that the patient had seemed increasingly confused in the last 24 hours; this had initially been managed conservatively as a concussion symptom.
On examination, the patient was neurologically intact with mild confusion, reflected in an Abbreviated Mental Test Score (AMTS) of 8 out of 10. The patient reported no visual disturbance, and no further systemic pathology was identified. The patient was referred for computed tomography (CT) of the head which revealed a predominantly left-sided cerebral contusion without fracture to the skull with localized traumatic subarachnoid hemorrhage (Figure 1). This result was discussed with the regional neurosurgical center who elected for local admission and observation. No evidence of ocular pathology was present on the head CT. The patient was admitted to a medical bed for observation and consultation under neurology. Four days following admission, with symptom management and close observation, the patient became increasingly orientated. During a rehabilitative physiotherapy assessment, visual field difficulties were noted and the patient reporting that vision from his left eye was altered.
On examination, the patient demonstrated normal ocular movements and no external ocular injuries were appreciated. The patient described monocular diplopia on isolation of the left eye visual field. Under formal evaluation of his visual acuity using a Snellen chart, the patient had an intact right eye visual acuity (6/6), with a reduction in left eye visual acuity (3/6). The patient could not undergo ophthalmoscopy due to an unfavorable bright ward environment, a lack of mydriatic medication, and difficulty following instructions. As a result, the decision was made to proceed to ocular POCUS in the inpatient ward setting.
POCUS Assessment
The patient underwent ocular POCUS by a physician experienced in the modality. The patient was placed supine at a 45-degree bed angle. Given the report of left eye monocular diplopia, assessment began on the right eye which revealed optic nerve prominence, increased optic nerve sheath diameter (ONSD) consistent with papilledema (Figure 2 and Video S1). The quoted value of ONSD is taken from 3mm below the retinal insertion, using an upper limit of 5.0mm. The left globe also had papilledema with an ONSD of 7.8 mm (Figure 3)
On the assessment of the left eye, a dense irregular mass not fixed to the retina was also visualized (Figure 4). The dense intraorbital mass was seen rotating and the “washing machine sign” confirmed the lack of tethering of the mass to the retina through counter-rotation of the dense mass to the globe (Videos S2, S3). Given the presence of vitreous hemorrhage, a color waveform is applied to verify that central retinal arterial and venous flow is patent (Video S4). Given the patient’s positioning, the vitreous hemorrhage was seen to move inferioposteriorly from the probe with gravity.
Outcome
The ocular POCUS examination strongly supported the presence of intraocular hemorrhage within the left globe, which explained the patient’s monocular diplopia. Given the patient’s cerebral contusion and subarachnoid hemorrhage, the diagnosis of Terson syndrome was made.
The patient was urgently referred to ophthalmology for same-day review, who confirmed the presence of vitreous hemorrhage without complicating ocular features; the patient was referred for visual field testing. The patient remains under ophthalmology care and has an ongoing visual deficit. The current plan is for the patient to undergo regular visual field testing and close observation, aiming to avoid surgical intervention. Community neurorehabilitation continues as the patient suffers from a mild disability, personality changes, and chronic headaches.
Case Discussion
Terson syndrome is defined by the presence of vitreous or retinal hemorrhage (including pre-, intra-, and sub-retinal hemorrhage) in the context of intracranial hemorrhage, either arising from traumatic brain injury or subarachnoid hemorrhage. In the case of vitreous hemorrhage, this can be identified on ocular POCUS by the presence of a non-tethered dense mass within the globe. The gold standard for the diagnostic evaluation of Terson syndrome remains dilated ophthalmoscopy. However ocular POCUS has been found to have high sensitivity (80%) and specificity (100%) for the diagnosis of Terson syndrome [6].
The Incidence of Terson syndrome remains unclear, with its presence potentially complicating more than 20% of all-cause subarachnoid hemorrhage (SAH) [7]. Terson syndrome is likely under-reported outside of scientific study due to a lack of evaluation and awareness of the syndrome. As a result, patients with monocular Terson syndrome often face significant delay in referral to specialty care [8]. It is important to note that delays in identifying Terson syndrome can result in poorer visual outcomes and associated morbidity. Patients with Terson syndrome who are not adequately managed are at risk of developing perimacular folds, retinal detachment, and ghost cell glaucoma [9].
The diagnosis of Terson syndrome can provide insight into the generalised clinical course in cases of intracranial hemorrhage. When grading head CTs using the Fisher scale, patients with low-grade SAH (grade I/II) are statistically unlikely to develop Terson syndrome when compared to those with high-grade SAH (grade III/IV) [10]. The only independent predictor of Terson syndrome is raised intracranial pressure; however, the presence of Terson syndrome is associated with increasingly severe neurological impairment using Glasgow Coma Score and Hunt and Hess grading, higher mortality, and poorer overall neurological outcomes [11]. It is important to note, however, that Terson syndrome may be present in patients with limited neurological compromise who make a full neurological recovery [12].
The mechanism by which Terson syndrome develops remains unclear, although as previously discussed, it is likely that raised intracranial pressure is important to its development [10]. One proposed mechanism is that of glymphatic reflux, in which a reversal of the intraocular to subarachnoid glymphatic flow occurs. This would occur due to intraocular pressures suddenly being overcome by increases in intracranial pressure. In such a mechanism, intraocular blood products are derived directly from the subarachnoid hemorrhage [13]. This mechanism may explain unilateral presentations of Terson syndrome given glymphatic flow is localised to each globe, particularly in cases where hemorrhage is limited to one cerebral hemisphere [14]. Alternatively, optic nerve sheath compression due to raised intracranial pressure and increased central retinal vein pressure may lead to venous vascular dysfunction and associated hemorrhage [15]. Alternative causes of acute raised intracranial pressure seldom propagate intraocular hemorrhage. Given this, it appears likely that the presence of intracranial hemorrhage, even in cases where hemorrhage is localised such as traumatic brain injury, is critical to the development of Terson syndrome.
In the case described above, ONSD was increased, but this was not isolated to the globe adjacent to the cerebral contusion. The role of ONSD generally, as well as its role in determining intracranial pressure, remains controversial. Given the determination of ONSD as a skill can be taught rapidly and in a reproducible manner, its use has expanded rapidly within the field of ocular POCUS [16]. Smaller studies have shown ONSD to have a high correlation with raised intracranial pressure [17]. To this end, meta-analysis has shown that although ONSD correlation with raised intracranial pressure is present, caution should still be taken in its use [18]. Given how glymphatic reflux may play a fundamental role in the development of intraocular hemorrhage in Terson syndrome, ONSD may be less reliable in these patients. There has been no study to date exploring ONSD within the Terson syndrome cohort.
Conclusion
Terson syndrome is an important but challenging diagnosis in the acute care of patients suffering from intracranial injury. There are often significant delays in the diagnosis of Terson syndrome, leading to increased morbidity in patients requiring already requiring complex neurorehabilitation. This case illustrates that Ocular POCUS can be used to make a rapid diagnosis of Terson syndrome on the medical floor.
Disclosures
No conflicts of interest to declare, and all ethical guidance is followed where appropriate.
Patient Consent
Informed patient consent has been given to publish the respective imaging and information; all case data is anonymized in line with General Medical Council, local, and publisher guidance.
Supplementary Material
References
1. Maegele M, Lefering R, Sakowitz O, Kopp MA, Schwab JM, Steudel WI, Unterberg A, Hoffmann R, Uhl E, Marzi I. The Incidence and Management of Moderate to Severe Head Injury. Dtsch Arztebl Int. 2019 Mar 8;116(10):167-173. doi: 10.3238/arztebl.2019.0167. PMID: 30995953; PMCID: PMC6482369.
2. Heath Jeffery RC, Dobes J, Chen FK. Eye injuries: Understanding ocular trauma. Aust J Gen Pract. 2022 Jul;51(7):476-482. doi: 10.31128/AJGP-03-21-5921. PMID: 35773155.
3. Biousse V, Bruce BB, Newman NJ. Ophthalmoscopy in the 21st century: The 2017 H. Houston Merritt Lecture. Neurology. 2018 Jan 23;90(4):167-175. doi: 10.1212/WNL.0000000000004868. Epub 2017 Dec 22. PMID: 29273687; PMCID: PMC5798658.
4. Flitcroft DI, Westcott M, Wormald R, Touquet R. Who should see eye casualties?: a comparison of eye care in an accident and emergency department with a dedicated eye casualty. J Accid Emerg Med. 1995 Mar;12(1):23-7.doi: 10.1136/emj.12.1.23. PMID: 7640823; PMCID: PMC1342512.
5. Al-Najmi YA, Subki AH, Alzaidi NS, Butt NS, Alsammahi AA, Madani FM, Alsallum MS, Al-Harbi RS, Alhibshi NM. Medical Schools’ Ophthalmology Course: An Appraisal by Ophthalmology Residents. Int J Gen Med. 2021 Nov 17;14:8365-8372. doi: 10.2147/IJGM.S330044. PMID: 34819744; PMCID: PMC8607127.
6. Czorlich P, Burkhardt T, Knospe V, Richard G, Vettorazzi E, Wagenfeld L, Westphal M, Regelsberger J, Skevas C. Ocular ultrasound as an easy applicable tool for detection of Terson’s syndrome after aneurysmal subarachnoid hemorrhage. PLoS One. 2014 Dec 11;9(12):e114907. doi: 10.1371/journal.pone.0114907. PMID: 25502695; PMCID: PMC4263478.
7. Seif GI, Teichman JC, Reddy K, Martin C, Rodriguez AR. Incidence, morbidity, and mortality of Terson syndrome in Hamilton, Ontario. Can J Neurol Sci. 2014 Sep;41(5):572-6. doi: 10.1017/cjn.2014.7. PMID: 25373806.
8. Gnanaraj L, Tyagi AK, Cottrell DG, Fetherston TJ, Richardson J, Stannard KP, Inglesby DV. Referral delay and ocular surgical outcome in Terson syndrome. Retina. 2000;20(4):374-7. doi: 10.1097/00006982-200007000-00009. PMID: 10950415.
9. Lima-Fontes M, Leuzinger-Dias M, Rodrigues R, Barros-Pereira R, Falcão M, Fernandes V, Alves-Faria P, Falcão-Reis F, Rocha-Sousa A. Terson Syndrome – Clinical Presentation, Management, and Visual Outcomes in a Tertiary Centre. Clin Ophthalmol. 2023 Jan 25;17:351-359. doi: 10.2147/OPTH.S396781. PMID: 36721665; PMCID: PMC9884450.
10. Stienen MN, Lücke S, Gautschi OP, Harders A. Terson haemorrhage in patients suffering aneurysmal subarachnoid haemorrhage: a prospective analysis of 60 consecutive patients. Clin Neurol Neurosurg. 2012 Jul;114(6):535-8. doi: 10.1016/j.clineuro.2011.10.034. Epub 2012 Apr 1. PMID: 22472353.
11. Czorlich P, Skevas C, Knospe V, Vettorazzi E, Westphal M, Regelsberger J. Terson’s syndrome – Pathophysiologic considerations of an underestimated concomitant disease in aneurysmal subarachnoid hemorrhage. J Clin Neurosci. 2016 Nov;33:182-186. doi: 10.1016/j.jocn.2016.04.015. Epub 2016 Jul 21. PMID: 27452126
12. Kang HM, Cho JM, Kim SY, Choi JH. Clinical characteristics of asymptomatic Terson syndrome in the patients with aneurysmal subarachnoid hemorrhage. Int J Ophthalmol. 2020 Feb 18;13(2):292-300. doi: 10.18240/ijo.2020.02.14. PMID: 32090040; PMCID: PMC7013785.
13. Kumaria A, Gruener AM, Dow GR, Smith SJ, Macarthur DC, Ingale HA. An explanation for Terson syndrome at last: the glymphatic reflux theory. J Neurol. 2022 Mar;269(3):1264-1271. doi: 10.1007/s00415-021-10686-4. Epub 2021 Jun 25. PMID: 34170402.
14. Wang X, Lou N, Eberhardt A, Yang Y, Kusk P, Xu Q, Förstera B, Peng S, Shi M, Ladrón-de-Guevara A, Delle C, Sigurdsson B, Xavier ALR, Ertürk A, Libby RT, Chen L, Thrane AS, Nedergaard M. An ocular glymphatic clearance system removes β-amyloid from the rodent eye. Sci Transl Med. 2020 Mar 25;12(536):eaaw3210. doi: 10.1126/scitranslmed.aaw3210. PMID: 32213628; PMCID: PMC7356596.
15. Hayreh SS. Pathogenesis of Terson syndrome. Indian Journal Ophthalmology. 2022 Dec;70(12):4130-4137. doi: 10.4103/ijo.IJO_1359_22. PMID: 36453300; PMCID: PMC9940578.
16. Kang SY, Yoo J, Park S, Jo IJ, Kim S, Cho H, Lee G, Park JE, Kim T, Lee SU, Hwang SY, Cha WC, Shin TG, Yoon H. Online Learning versus Hands-On Learning of Basic Ocular Ultrasound Skills: A Randomized Controlled Non-Inferiority Trial. Medicina (Kaunas). 2022 Jul 20;58(7):960. doi: 10.3390/medicina58070960. PMID: 35888678; PMCID: PMC9315691.
17. Amini A, Kariman H, Arhami Dolatabadi A, Hatamabadi HR, Derakhshanfar H, Mansouri B, Safari S, Eqtesadi R. Use of the sonographic diameter of optic nerve sheath to estimate intracranial pressure. Am J Emerg Med. 2013 Jan;31(1):236-9. doi: 10.1016/j.ajem.2012.06.025. Epub 2012 Aug 31. PMID: 22944553.
18. Robba C, Santori G, Czosnyka M, Corradi F, Bragazzi N, Padayachy L, Taccone FS, Citerio G. Optic nerve sheath diameter measured sonographically as non-invasive estimator of intracranial pressure: a systematic review and meta-analysis. Intensive Care Med. 2018 Aug;44(8):1284-1294. doi: 10.1007/s00134-018-5305-7. Epub 2018 Jul 17. PMID: 30019201.